83_FR_3366 83 FR 3350 - Office of the Director, National Institutes of Health; Notice of Meeting

83 FR 3350 - Office of the Director, National Institutes of Health; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 16 (January 24, 2018)

Page Range3350-3351
FR Document2018-01193

Federal Register, Volume 83 Issue 16 (Wednesday, January 24, 2018) 
[Federal Register Volume 83, Number 16 (Wednesday, January 24, 2018)]
[Notices]
[Pages 3350-3351]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-01193]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the NIH Clinical Center 
Research Hospital Board.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as 
amended because the premature disclosure of program documents--PAC and 
the discussions would likely to significantly frustrate implementation 
of recommendations.

    Name of Committee: NIH Clinical Center Research Hospital Board.
    Date: February 2, 2018.
    Open: 9:00 a.m. to 3:10 p.m.
    Agenda: Patient Safety at the CC--Right Path; Patient & Staff 
Safety Beyond Stars; Center for Cellular Engineering.
    Place: National Institutes of Health, Building 31, 6th Floor, 
Conference Room: 6C6, 31 Center Drive, Bethesda, MD 20892.
    Closed: 3:10 p.m. to 5:00 p.m.
    Agenda: To review and evaluate identification of candidates for 
leadership roles.
    Place: National Institutes of Health, Building 31, 6th Floor, 
Conference Room: 6C6, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Gretchen Wood, Staff Assistant, Office of the 
Director, National Institutes of Health, One Center Drive, Building 
1, Room 126, Bethesda, MD 20892, 301-496-4272, [email protected].
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)


[[Page 3351]]


    Dated: January 18, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-01193 Filed 1-23-18; 8:45 am]
 BILLING CODE 4140-01-P

3350 Federal Register / Vol. 83, No. 16 / Wednesday, January 24, 2018 / Notices property such as patentable material, for the review, discussion, and amended, notice is hereby given of a and personal information concerning evaluation of individual intramural meeting of the NIH Clinical Center individuals associated with the grant programs and projects conducted by the Research Hospital Board. applications, the disclosure of which National Cancer Institute, including The meeting will be open to the would constitute a clearly unwarranted consideration of personnel public as indicated below, with invasion of personal privacy. qualifications and performance, and the attendance limited to space available. Name of Committee: National Institute of competence of individual investigators, Individuals who plan to attend and Mental Health Special Emphasis Panel; Early the disclosure of which would need special assistance, such as sign Phase and Career Development— constitute a clearly unwarranted language interpretation or other Pathophysiology and Clinical Trials. invasion of personal privacy. reasonable accommodations, should Date: February 13, 2018. Name of Committee: Board of Scientific notify the Contact Person listed below Time: 1:30 p.m. to 5:00 p.m. in advance of the meeting. Counselors for Basic Sciences, National Agenda: To review and evaluate grant The meeting will be closed to the Cancer Institute. applications. Date: March 12, 2018. public in accordance with the Place: National Institutes of Health, Time: 9:00 a.m. to 3:30 p.m. provisions set forth in section Neuroscience Center, 6001 Executive Agenda: To review and evaluate personal Boulevard, Rockville, MD 20852 (Virtual 552b(c)(9)(B), Title 5 U.S.C., as amended qualifications and performance, and because the premature disclosure of Meeting). competence of individual investigators. Contact Person: David I. Sommers, Ph.D., program documents—PAC and the Place: National Institutes of Health, 31 Scientific Review Officer, Division of Center Drive, Building 31, Wing C; 6th Floor, discussions would likely to significantly Extramural Activities, National Institute of Conference Room 6, Bethesda, MD 20892. frustrate implementation of Mental Health, National Institutes of Health, Contact Person: Mehrdad Tondravi, Ph.D., recommendations. 6001 Executive Blvd., Room 6154, MSC 9606, Chief, Institute Review Office, Office of the Bethesda, MD 20892, 301–443–7861, Name of Committee: NIH Clinical Center Director, National Cancer Institute, National Research Hospital Board. dsommers@mail.nih.gov. Institutes of Health, 9609 Medical Center, Date: February 2, 2018. Name of Committee: National Institute of Room 3W302, Bethesda, MD 20892–9750, Open: 9:00 a.m. to 3:10 p.m. Mental Health Special Emphasis Panel; 240–276–5664, tondravim@mail.nih.gov. Agenda: Patient Safety at the CC—Right Addressing Suicide Research Gaps: Name of Committee: Board of Scientific Path; Patient & Staff Safety Beyond Stars; Aggregating and Mining Existing Data Sets Counselors for Clinical Sciences and Center for Cellular Engineering. for Secondary Analyses. Epidemiology National Cancer Institute. Place: National Institutes of Health, Date: February 16, 2018. Date: March 13, 2018. Building 31, 6th Floor, Conference Room: Time: 9:00 a.m. to 5:00 p.m. Time: 9:00 a.m. to 2:30 p.m. 6C6, 31 Center Drive, Bethesda, MD 20892. Agenda: To review and evaluate grant Agenda: To review and evaluate personal Closed: 3:10 p.m. to 5:00 p.m. applications. qualifications and performance, and Agenda: To review and evaluate Place: National Institutes of Health, competence of individual investigators. identification of candidates for leadership Neuroscience Center, 6001 Executive Place: National Institutes of Health, 31 roles. Boulevard, Rockville, MD 20852 (Virtual Center Drive, Building 31, Wing C; 6th Floor, Place: National Institutes of Health, Meeting). Conference Room 6, Bethesda, MD 20892. Building 31, 6th Floor, Conference Room: Contact Person: Marcy Ellen Burstein, Contact Person: Brian E. Wojcik, Ph.D., 6C6, 31 Center Drive, Bethesda, MD 20892. Ph.D., Scientific Review Officer, Division of Senior Review Administrator, Institute Contact Person: Gretchen Wood, Staff Extramural Activities, National Institute of Review Office, Office of the Director, Assistant, Office of the Director, National Mental Health, NIH Neuroscience Center, National Cancer Institute, National Institutes Institutes of Health, One Center Drive, 6001 Executive Blvd., Room 6143, MSC 9606, of Health, 9609 Medical Center, Room Building 1, Room 126, Bethesda, MD 20892, Bethesda, MD 20892–9606, 301–443–9699, 3W414, Bethesda, MD 20892–9750, 240–276– 301–496–4272, woodgs@nih.gov. bursteinme@mail.nih.gov. 5664, wojcikb@mail.nih.gov. Any interested person may file written (Catalogue of Federal Domestic Assistance (Catalogue of Federal Domestic Assistance comments with the committee by forwarding Program No. 93.242, Mental Health Research Program Nos. 93.392, Cancer Construction; the statement to the Contact Person listed on Grants, National Institutes of Health, HHS) 93.393, Cancer Cause and Prevention this notice. The statement should include the Research; 93.394, Cancer Detection and name, address, telephone number and when Dated: January 18, 2018. Diagnosis Research; 93.395, Cancer applicable, the business or professional Melanie J. Pantoja, Treatment Research; 93.396, Cancer Biology affiliation of the interested person. Program Analyst, Office of Federal Advisory Research; 93.397, Cancer Centers Support; In the interest of security, NIH has Committee Policy. 93.398, Cancer Research Manpower; 93.399, instituted stringent procedures for entrance Cancer Control, National Institutes of Health, onto the NIH campus. All visitor vehicles, [FR Doc. 2018–01201 Filed 1–23–18; 8:45 am] HHS) including taxicabs, hotel, and airport shuttles BILLING CODE 4140–01–P Dated: January 18, 2018. will be inspected before being allowed on Melanie Pantoja, campus. Visitors will be asked to show one form of identification (for example, a DEPARTMENT OF HEALTH AND Program Analyst, Office of Federal Advisory government-issued photo ID, driver’s license, HUMAN SERVICES Committee Policy. or passport) and to state the purpose of their [FR Doc. 2018–01188 Filed 1–23–18; 8:45 am] visit. National Institutes of Health BILLING CODE 4140–01–P (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research National Cancer Institute; Notice of Training Award; 93.22, Clinical Research Closed Meetings DEPARTMENT OF HEALTH AND Loan Repayment Program for Individuals Pursuant to section 10(d) of the HUMAN SERVICES from Disadvantaged Backgrounds; 93.232, daltland on DSKBBV9HB2PROD with NOTICES Federal Advisory Committee Act, as Loan Repayment Program for Research National Institutes of Health Generally; 93.39, Academic Research amended, notice is hereby given of the Enhancement Award; 93.936, NIH Acquired following meetings. Office of the Director, National Immunodeficiency Syndrome Research Loan The meetings will be closed to the Repayment Program; 93.187, Undergraduate Institutes of Health; Notice of Meeting public as indicated below in accordance Scholarship Program for Individuals from with the provisions set forth in section Pursuant to section 10(d) of the Disadvantaged Backgrounds, National 552b(c)(6), Title 5 U.S.C., as amended Federal Advisory Committee Act, as Institutes of Health, HHS) VerDate Sep<11>2014 20:25 Jan 23, 2018 Jkt 244001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\24JAN1.SGM 24JAN1

Federal Register / Vol. 83, No. 16 / Wednesday, January 24, 2018 / Notices 3351 Dated: January 18, 2018. Name of Committee: National Cancer Time: 12:30 p.m. to 3:30 p.m. Sylvia L. Neal, Institute Special Emphasis Panel, TEP–7B: Agenda: To review and evaluate grant Models for Disparity Research. applications. Program Analyst, Office of Federal Advisory Date: February 22, 2018. Place: National Cancer Institute, Shady Committee Policy. Time: 12:00 p.m. to 3:00 p.m. Grove, 9609 Medical Center Drive, Room [FR Doc. 2018–01193 Filed 1–23–18; 8:45 am] Agenda: To review and evaluate contract 7W104, Rockville, MD 20850 (Telephone BILLING CODE 4140–01–P proposals. Conference Call). Place: National Cancer Institute, Shady Contact Person: Eun Ah Cho, Ph.D., Grove, 9609 Medical Center Drive, Room Scientific Review Officer, Special Review DEPARTMENT OF HEALTH AND 1E030, Rockville, MD 20850 (Telephone Branch, Division of Extramural Activities, HUMAN SERVICES Conference Call). National Cancer Institute, NIH, 9609 Medical Contact Person: Jeffrey E. DeClue, Ph.D., Center Drive, Room 7W104, Bethesda, MD National Institutes of Health Scientific Review Officer, Research 20892–9750, 240–276–6342, choe@ Technology and Contract Review Branch, mail.nih.gov. National Cancer Institute; Notice of Division of Extramural Activities, National Name of Committee: National Cancer Cancer Institute, NIH, 9609 Medical Center Institute Special Emphasis Panel, NCI Closed Meetings Drive, Room 7W114, Bethesda, MD 20892– Program Project VII (P01) Review. 9750, 240–276–6371, decluej@mail.nih.gov. Date: March 2, 2018. Pursuant to section 10(d) of the Name of Committee: National Cancer Time: 8:00 a.m. to 5:00 p.m. Federal Advisory Committee Act, as Institute Special Emphasis Panel; Physical Agenda: To review and evaluate grant amended, notice is hereby given of the Science—Oncology Projects. applications. following meetings. Date: February 23, 2018. Place: Bethesda North Marriott Hotel & The meetings will be closed to the Time: 12:00 p.m. to 5:00 p.m. Conference Center, 5701 Marinelli Road, public in accordance with the Agenda: To review and evaluate grant Bethesda, MD 20852. provisions set forth in sections applications. Contact Person: Clifford W. Schweinfest, Place: National Cancer Institute, Shady Ph.D., Scientific Review Officer, Special 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Grove, 9609 Medical Center Drive, Room Review Branch, Division of Extramural as amended. The grant applications 7W242, Rockville, MD 20850 (Telephone Activities, National Cancer Institute, NIH, and/or contract proposals and the Conference Call). 9609 Medical Center Drive, Room 7W108, discussions could disclose confidential Contact Person: Zhiqiang Zou, MD, Ph.D., Bethesda, MD 20892–9750, 240–276–6343, trade secrets or commercial property Scientific Review Officer, Special Review schweinfestcw@mail.nih.gov. such as patentable material, and Branch, Division of Extramural Activities, Name of Committee: National Cancer personal information concerning National Cancer Institute, NIH, 9609 Medical Institute Special Emphasis Panel, Innovative individuals associated with grant Center Drive, Room 7W242, Bethesda, MD Molecular and Cellular Analysis applications and/or contract proposals, 20892–9750, 240–276–6372, zouzhiq@ Technologies (IMAT). mail.nih.gov. Date: March 2, 2018. the disclosure of which would constitute a clearly unwarranted Name of Committee: National Cancer Time: 8:00 a.m. to 5:00 p.m. Institute Initial Review Group, Subcommittee Agenda: To review and evaluate grant invasion of personal privacy. J—Career Development. applications. Name of Committee: National Cancer Date: February 28–March 1, 2018. Place: Bethesda North Marriott Hotel & Institute Special Emphasis Panel, SEP 7: NCI Time: 8:00 a.m. to 4:00 p.m. Conference Center, 5701 Marinelli Road, Clinical and Translational Exploratory/ Agenda: To review and evaluate grant Bethesda, MD 20852. Developmental Studies. applications. Contact Person: Yasuko Furumoto, Ph.D., Date: February 16, 2018. Place: Bethesda North Marriott Hotel & Scientific Review Officer, Research Time: 7:00 a.m. to 6:00 p.m. Conference Center, 5701 Marinelli Road, Technology and Contract Review Branch, Agenda: To review and evaluate grant North Bethesda, MD 20852. Division of Extramural Activities, National applications. Contact Person: Tushar Deb, Ph.D., Cancer Institute, NIH, 9609 Medical Center Place: Hyatt Regency Bethesda, One Scientific Review Officer, Resources and Drive, Room 7W424, Bethesda, MD 20892– Bethesda Metro Center, 7400 Wisconsin Training Review Branch, Division of 9750, 240–276–5287, yasuko.furumoto@ Avenue, Bethesda, MD 20814. Extramural Activities, National Cancer nih.gov. Contact Person: Robert S. Coyne, Ph.D., Institute, NIH, 9609 Medical Center Drive, Name of Committee: National Cancer Scientific Review Officer, Special Review Room 7W624, Bethesda, MD 20892–9750, Institute Special Emphasis Panel, Branch, Division of Extramural Activities, 240–276–6132, tushar.deb@nih.gov. Cooperative Agreement to Develop Targeted National Cancer Institute, NIH, 9609 Medical Name of Committee: National Cancer Agents for Use with Systemic Agents plus Center Drive, Room 7W236, Bethesda, MD Institute Special Emphasis Panel, U01 Radiotherapy. 20892–9750, 240–276–5120, coyners@ Conference Grant Review. Date: March 2, 2018. mail.nih.gov. Date: February 28, 2018. Time: 10:00 a.m. to 12:00 p.m. Name of Committee: National Cancer Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant Institute Special Emphasis Panel, TEP–7A: Agenda: To review and evaluate grant applications. Cancer Symptom Management. applications. Place: National Cancer Institute, Shady Date: February 21, 2018. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room Time: 10:00 a.m. to 5:00 p.m. Grove, 9609 Medical Center Drive, Room 7W640, Rockville, MD 20850 (Telephone Agenda: To review and evaluate contract 7W556, Rockville, MD 20850 (Telephone Conference Call). proposals. Conference Call). Contact Person: Saejeong J. Kim, Ph.D., Place: National Cancer Institute, Shady Contact Person: Bratin K. Saha, Ph.D., Scientific Review Officer, Special Review Grove, 9609 Medical Center Drive, Room Scientific Review Officer, Program Branch, Division of Extramural Activities, 1E030, Rockville, MD 20850 (Telephone Coordination and Referral Branch, Division National Cancer Institute, NIH, 9609 Medical daltland on DSKBBV9HB2PROD with NOTICES Conference Call). of Extramural Activities, National Cancer Center Drive, Room 7W640, Bethesda, MD Contact Person: Jeffrey E. DeClue, Ph.D., Institute, NIH, 9609 Medical Center Drive, 20892–9750, 240–276–5179, saejeong.kim@ Scientific Review Officer, Research Room 7W556, Bethesda, MD 20892–9750, nih.gov. Technology and Contract Review Branch, 240–276–6411, sahab@mail.nih.gov. Name of Committee: National Cancer Division of Extramural Activities, National Name of Committee: National Cancer Institute Special Emphasis Panel, SEP–1B: Cancer Institute, NIH, 9609 Medical Center Institute Special Emphasis Panel, Multilevel NCI Clinical and Translational Exploratory/ Drive, Room 7W114, Bethesda, MD 20892– Interventions in Cancer Care Delivery. Developmental Studies. 9750, 240–276–6371, decluej@mail.nih.gov. Date: February 28, 2018. Date: March 2, 2018. VerDate Sep<11>2014 20:25 Jan 23, 2018 Jkt 244001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\24JAN1.SGM 24JAN1


Document Created: 2018-10-26 10:01:03
Document Modified: 2018-10-26 10:01:03
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesFebruary 2, 2018.
FR Citation83 FR 3350 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR